Key facts
- This page summarizes David A. Rosa's Form 4 filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Apr 2026, 16:01.
David A. Rosa - 31 Mar 2026 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- NMTC
- Reported as of
- 31 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2026, 16:01:06 UTC
- Prior SEC filing
- 20 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Emily Johns, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David A. Rosa filed Form 4 for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) on 01 Apr 2026.
Change
- Previous filing in this sequence was filed on 20 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001540354
Primary reporting owner
Rosa David A
- Relationship
- CEO and President, Director
- Address
- 7599 ANAGRAM DR., EDEN PRAIRIE
- Signature
- /s/ Emily Johns, by Power of Attorney
- Signature date
- 01 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NMTC
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -2,458
- Change %
- -0.23%
- Price
- $0.7770*
- Shares after
- 1,080,132
- Date
- 31 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.